Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination

Mol Cell. 2022 Apr 21;82(8):1528-1542.e10. doi: 10.1016/j.molcel.2022.01.021. Epub 2022 Mar 3.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a global health concern with no approved drugs. High-protein dietary intervention is currently the most effective treatment. However, its underlying mechanism is unknown. Here, using Drosophila oenocytes, the specialized hepatocyte-like cells, we find that dietary essential amino acids ameliorate hepatic steatosis by inducing polyubiquitination of Plin2, a lipid droplet-stabilizing protein. Leucine and isoleucine, two branched-chain essential amino acids, strongly bind to and activate the E3 ubiquitin ligase Ubr1, targeting Plin2 for degradation. We further show that the amino acid-induced Ubr1 activity is necessary to prevent steatosis in mouse livers and cultured human hepatocytes, providing molecular insight into the anti-NAFLD effects of dietary protein/amino acids. Importantly, split-intein-mediated trans-splicing expression of constitutively active UBR2, an Ubr1 family member, significantly ameliorates obesity-induced and high fat diet-induced hepatic steatosis in mice. Together, our results highlight activation of Ubr1 family proteins as a promising strategy in NAFLD treatment.

Keywords: Plin2; Ubr1; amino acid; autoinhibition; hepatic steatosis; isoleucine; leucine; lipid droplet; nonalcoholic fatty liver disease; ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Essential / metabolism
  • Amino Acids, Essential / pharmacology
  • Amino Acids, Essential / therapeutic use
  • Animals
  • Diet, High-Fat / adverse effects
  • Hepatocytes / metabolism
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Non-alcoholic Fatty Liver Disease* / prevention & control
  • Ubiquitination

Substances

  • Amino Acids, Essential